Protective Effect of Asacol in Combination with Pantoprazole in Ulcerative Colitis Patients Who Defecate Asacol Tablets Intactly: A Clinical Trial Study

Figures & data

Table 1 Demographic and Clinical Characteristics of 30 Patients with UC Following Treatment with Pantoprazole

Categories	Daily Stool Frequency: (mean ± sd)		P-value	Visible Blood in Stool: Number (%)		P-value
	Without Pantoprazole	With Pantoprazole		Without Pantoprazole	With Pantoprazole
Age group (years)
18–40	6± 0.91	1.46± 0.51	0.001*	13 (100)	0	0.001*
41–60	6.11± 1.16	1.52± 0.51	0.001*	17 (100)	0	0.001*
Sex
Male	6± 1.18	1.27± 0.46	0.003*	11 (100)	0	0.001*
Female	6.1± 0.99	1.63± 0.49	0.001*	19 (100)	0	0.001*
BMI					0
Normal	6 ± 1.11	1.66± 0.5	0.007*	9 (100)	0	0.004*
Obese	6.09± 1.04	1.42± 0.5	0.001*	21 (100)	0	0.001*

Note: *P<0.05 was considered significant.